Drawing for CELLFX

USPTO serial 87982083

CELLFX

Reviewed by CopyMark Law Group

Reg. 5921900Status 702Registered
Filing date
Status date
Registration date
Nov 26, 2019
Examiner
BLANDU, FLORENTINA
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CELLFX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lena Vinitskaya

Lena Vinitskaya Pulse Biosciences, Inc.3957 Point Eden WayLegal Dept.Hayward, CA 94545

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus and devices for treatment in the nature of pulsed electrical destruction or reduction of benign and non-benign biological tissues; medical devices using pulsed electricity for use in treating skin growth, skin lesions and skin conditions; medical devices, namely, medical pulse generators and pulse generator circuits for tissue modification, manipulation and/or ablation; medical apparatus designed for use with nanopulse electricity for manipulation, modification and/or ablation of biologic tissue; medical apparatus, devices and instruments utilizing electrical pulsing technology for [ prevention, detection, diagnosis and ] treatment of medical disease, injuries and conditions, namely, tumors, skin and tissue disorders, warts, viruses, [ papillomas, ] and other tissue and skin growths; medical systems comprising medical devices in the nature of pulse generators, pulse generator circuits, medical probes, medical wands, medical electrodes and microneedle treatment tips for use in tissue modification, manipulation and /or ablation; medical and surgical devices, and medical systems and accessories comprised of skin marking tools, guides for placement of medical electrodes on lesions or tumors all for [ diagnosis and ] treatment of tissue [ and blood ] diseases, conditions and abnormalities; medical pulse generators and medical electrodes for nanosecond pulse delivery for treatment of medical conditions or cosmetic tissue defects; medical device accessories to enable treatment of biological tissues, namely, microneedle treatment tips, medical electrodes, electric medical connectors, medical handpieces, medical probes to access internal and external anatomical areas and coupling gels sold as a unit, and tissue marking tools; all of which exclude apparatus and devices for the treatment of celluliteACTIVENov 12, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 29, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 29, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 29, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 5, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Nov 26, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 26, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 23, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 22, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 15, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 15, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 9, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 9, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 9, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Sep 5, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 4, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 29, 2019IUAFUSE AMENDMENT FILED—
Aug 29, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Aug 29, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 29, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 24, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 26, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 13, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Feb 4, 2019CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Feb 1, 2019APETASSIGNED TO PETITION STAFF—
Jan 23, 2019EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 9, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 11, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 11, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 22, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 9, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2018DOCKASSIGNED TO EXAMINER—
Jul 2, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 2, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2018ALIEASSIGNED TO LIE—
Jun 13, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2018DOCKASSIGNED TO EXAMINER—
Jan 23, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 12, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance